This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 

AstraZeneca settles Crestor patent dispute


UK pharmaceutical company AstraZeneca has reached a settlement with Actavis and Egis Pharmaceuticals that delays the release of generic versions of its cholesterol treatment Crestor. 

AstraZeneca, Watson, Actavis, Egis, Crestor, settlement, generic


Payment types accepted